Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California. Show more

333 South Grand Avenue, Los Angeles, CA, 90071, United States

Shell Companies
Financial Services
Start AI Chat

Market Cap

262.8M

52 Wk Range

$9.99 - $10.85

Previous Close

$10.69

Open

$10.63

Volume

84,730

Day Range

$10.63 - $10.63

Enterprise Value

257.7M

Cash

1.329M

Avg Qtr Burn

-56.52K

Insider Ownership

0.00%

Institutional Own.

90.40%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date